SEC Form 4 · accession 0001209191-17-032131
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn A. Torres
Officer — SVP- Employer&Payer Engagement
Period of report
May 10, 2017
Accepted (ET)
May 12, 2017 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2017 | M | 4,300 | $22.95 | A | 5,496 | D | |
| Common Stock | May 10, 2017 | F | 2,015 | $85.56 | D | 3,481 | D | |
| Common StockF1 | May 10, 2017 | S | 1,196 | $85.6933 | D | 2,285 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF2 | $22.95 | May 10, 2017 | M | 4,300 | D | — | Feb 8, 2022 | Common Stock | 4,300 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.69 to $85.695, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The stock appreciation rights vested at the end of fiscal years 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.